A dynamic model of the intestinal epithelium integrates multiple sources of preclinical data and enables clinical translation of drug‐induced toxicity
Open Access
- 11 September 2023
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 12 (10) , 1511-1528
Abstract
We have built a quantitative systems toxicology modeling framework focused on the early prediction of oncotherapeutic‐induced clinical intestinal adverse effects. The model describes stem and progenitor cell dynamics in the small intestinal epithelium and integrates heterogeneous epithelial‐related processes, such as transcriptional profiles, citrulline kinetics, and probability of diarrhea. We fitted a mouse‐specific version of the model to quantify doxorubicin and 5‐fluorouracil (5‐FU)‐induced toxicity, which included pharmacokinetics and 5‐FU metabolism and assumed that both drugs led to cell cycle arrest and apoptosis in stem cells and proliferative progenitors. The model successfully recapitulated observations in mice regarding dose‐dependent disruption of proliferation which could lead to villus shortening, decrease of circulating citrulline, increased diarrhea risk, and transcriptional induction of the p53 pathway. Using a human‐specific epithelial model, we translated the cytotoxic activity of doxorubicin and 5‐FU quantified in mice into human intestinal injury and predicted with accuracy clinical diarrhea incidence. However, for gefitinib, a specific‐molecularly targeted therapy, the mice failed to reproduce epithelial toxicity at exposures much higher than those associated with clinical diarrhea. This indicates that, regardless of the translational modeling approach, preclinical experimental settings have to be suitable to quantify drug‐induced clinical toxicity with precision at the structural scale of the model. Our work demonstrates the usefulness of translational models at early stages of the drug development pipeline to predict clinical toxicity and highlights the importance of understanding cross‐settings differences in toxicity when building these approaches.Keywords
This publication has 59 references indexed in Scilit:
- The Simcyp Population Based Simulator: Architecture, Implementation, and Quality AssuranceIn Silico Pharmacology, 2013
- Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomesThe EMBO Journal, 2011
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based managementTherapeutic Advances in Medical Oncology, 2009
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancerProceedings of the National Academy of Sciences, 2007
- A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal cryptJournal of Theoretical Biology, 2007
- Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patientsInvestigational New Drugs, 2006
- Almost all about citrulline in mammalsAmino Acids, 2005
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group StudyJNCI: Journal of the National Cancer Institute, 1991